MRKR logo
MRKR NASDAQ US

Marker Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2016
$1.32
▲ +$0.01 (+0.76%)
Vol 94K
4
Quality Score
fail
Mkt Cap
$24.8M
ROE
-92.4%
Margin
-304.5%
D/E
0.00
Beta
1.44
52W
$1–$4

Wall Street Consensus

9 analysts · Apr 2026
2
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

Similar Stocks

LGVN
Longeveron Inc
$10.8M
SKYE
Skye Bioscience Inc
$24.0M
VTGN
Vistagen Therapeutics Inc
$26.1M
SNTI
Senti Biosciences Inc
$27.3M
CRIS
Curis Inc
$12.8M
TPST
Tempest Therapeutics Inc
$14.1M
JSPR
Jasper Therapeutics Inc
$51.2M

Earnings

Beat rate: 80.0%
Next Report May 13, 2026
EPS Estimate: $-0.19
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.19 — —
Dec 2025 $-0.20 $-0.09 +$0.11
Sep 2025 $-0.46 $-0.12 +$0.34
Jun 2025 $-0.42 $-0.29 +$0.13

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -114.6% -101.9% -114.6% -114.6% -114.6% -92.3%
P/E (TTM) — — — — — —
Net Margin -466.3% -224.4% -271.1% -271.1% -271.1% -304.5%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 3.45 6.79 3.45 3.45 3.45 6.50

Key Ratios

ROA (TTM)
-75.7%
P/S (TTM)
5.29
P/B
1.8
EPS (TTM)
$-1.23
CF/Share
$-0.74
Rev Growth 3Y
+74.5%
52W High
$4.07
52W Low
$0.81
$0.81 52-Week Range $4.07

How does MRKR compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MRKR AAPG ABEO ABOS ABP

MRKR valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.3
▼ 59% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.8
▼ 27% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MRKR profitability vs Biotechnology peers

ROE
-92.4%
▼ 37% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-304.5%
▼ 6% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-75.7%
▼ 62% below peers (-46.7%)
vs Peers
vs Industry
Weak

MRKR financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.5
▲ 46% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
1.4
▲ 48% above peers (1.0)
vs Peers
vs Industry
More volatile

MRKR fundamentals radar

MRKR Peer median Industry

MRKR profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MRKR vs peers: key metrics

Latest News

No related news yet